In addition, we steadily recruit new patients from print advertising (Depression/Anxiety/Panic), and NAMI referrals (Bipolar Disorder). We are immediately adjacent to a general medical hospital (Emory Adventist Hospital). We use central IRBs and, for inpatient studies, the Administrative Board at Ridgeview Institute co-endorses the decisions of the Central IRB. We do inpatient as well as outpatient studies in Depression, and Bipolar Disorder. We also are currently doing outpatient studies with Anxiety Disorders.

Our placebo response rates in the vast majority of depression trials have been between 17% and 38% with a mean of 27%, and we have consistently discriminated placebo from active comparator over the past 10 years. Our retention in six-week, double-blind depression trials is approximately 70%, and generally better when an extension phase is available as an incentive.

We enroll approximately 300 patients per year with a clear majority of these on Major Depression studies and a steadily growing minority in our Anxiety Disorder trials.

Our outpatient facility is staffed by two physicians and 3 research assistants, one medical records specialist, one regulatory administrative assistant, one finance officer, and one receptionist. We have also demonstrated the capability to perform Phase I-II "Bridging" studies.

Inpatient psychiatric nursing staff are trained in the research process. We have demonstrated rapid recruitment for our various inpatient psychiatric clinical trials, and have demonstrated excellent recruitment and retention in our previous "bridging" study.

Click here for the Rx Reference page.

If you are age 18 or older and are interested in learning more about our free programs, please call us at 770-333-0093.

Are you eligible?

info@carmanresearch.com

back to the top 

About Us | What's New | Facts | Clinical Trial Process
Phases | Criteria | Depression | Anxiety | Panic Disorder
Bipolar Disorder | Social Phobia | More Info | Rx